Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (Ki: 6.5 nM). It also has antitumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,400.00 | |
50 mg | 10-14 weeks | $ 1,820.00 | |
100 mg | 10-14 weeks | $ 2,810.00 |
Description | LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (Ki: 6.5 nM). It also has antitumor activity. |
Targets&IC50 | GARFT:(ki)6.5 nM, FRβ:18.2 nM(ki), FRα:1.78 nM(ki) |
In vitro | LY309887 is significantly cytotoxic against the human leukemia cell line CCRF-CEM (IC50: 9.9 nM). LY309887 also has high affinity at human folate receptor (FR)α and FRβ (Ki, 1.78 nM, and 18.2 nM, respectively) . |
In vivo | In mice bearing C3H mammary cancer cells, LY309887 (3 mg/kg-100 mg/kg, i.p.) displays complete inhibition on the tumor growth. |
Molecular Weight | 449.48 |
Formula | C19H23N5O6S |
CAS No. | 127228-54-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY309887 127228-54-0 Immunology/Inflammation LTR LY 309887 LY-309887 inhibitor inhibit